• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶体右旋糖酐分子量对人血清脂质的影响。

Effect of molecular weights of colloidal dextran on human serum lipids.

作者信息

PUCAR Z, KELER-BACOKA M

出版信息

Science. 1961 Oct 27;134(3487):1369-70. doi: 10.1126/science.134.3487.1369.

DOI:10.1126/science.134.3487.1369
PMID:14489101
Abstract

When 6-percent colloidal solutions of dextran (molecular weights, 10.000 to 500.000) are mixed with human serum in vitro, a new dextran-lipid fraction appears in paper strip electrophoresis between the starting point and the gamma globulins. The intensity of this dextran-lipid fraction increases with the progressive increase of molecular weight of the dextran used, and this increased intensity of the dextran-lipid fraction is accompanied simultaneously by an appropriate decrease of the lipid fraction migrating with the beta globulins. The intensity of the A-lipoproteins and the neutral fats adsorbed at the starting point seems unaltered by the application of dextran in colloidal solution regardless of the molecular weight of the dextran used. No change of the protein patterns was observed.

摘要

当将葡聚糖(分子量为10,000至500,000)的6%胶体溶液与人体血清在体外混合时,在纸条电泳中,起始点与γ球蛋白之间会出现一种新的葡聚糖-脂质组分。该葡聚糖-脂质组分的强度随着所用葡聚糖分子量的逐渐增加而增强,并且这种葡聚糖-脂质组分强度的增加同时伴随着与β球蛋白一起迁移的脂质组分的相应减少。无论所用葡聚糖的分子量如何,胶体溶液中葡聚糖的加入似乎都不会改变吸附在起始点的A-脂蛋白和中性脂肪的强度。未观察到蛋白质图谱有变化。

相似文献

1
Effect of molecular weights of colloidal dextran on human serum lipids.胶体右旋糖酐分子量对人血清脂质的影响。
Science. 1961 Oct 27;134(3487):1369-70. doi: 10.1126/science.134.3487.1369.
2
ESTIMATION OF THE LOW-DENSITY (BETA) LIPOPROTEINS OF SERUM IN HEALTH AND DISEASE USING LARGE MOLECULAR WEIGHT DEXTRAN SULPHATE.使用大分子量硫酸葡聚糖估计健康与疾病状态下血清中的低密度(β)脂蛋白
J Clin Pathol. 1964 Nov;17(6):627-43. doi: 10.1136/jcp.17.6.627.
3
[The effect of low and high molecular weight dextrans on selected lipid parameters in serum. Part 3].[低分子量和高分子量右旋糖酐对血清中选定脂质参数的影响。第3部分]
Z Gesamte Inn Med. 1993 Aug;48(8):381-5.
4
[Formation of high-molecular aggregates between serum amylase and colloidal plasma substitutes (author's transl)].
Anaesthesist. 1977 Nov;26(11):623-7.
5
Lipid changes caused by colloidal dextran added to human sera in different volume ratios.以不同体积比添加到人类血清中的胶体葡聚糖所引起的脂质变化。
Clin Chim Acta. 1966 Jul;14(1):24-6. doi: 10.1016/0009-8981(66)90059-3.
6
[On a characteristic property of plasmocytoma lipids with respect to serum lipid precipitation with a dextran sulfate solution].[关于浆细胞瘤脂质相对于硫酸葡聚糖溶液沉淀血清脂质的特性]
Clin Chim Acta. 1963 Mar;8:215-9. doi: 10.1016/0009-8981(63)90160-8.
7
ESTIMATION OF SERUM LIPOPROTEINS USING SULPHATED POLYSACCHARIDES.使用硫酸化多糖测定血清脂蛋白
Clin Chim Acta. 1964 Aug;10:123-33. doi: 10.1016/0009-8981(64)90156-1.
8
[Effect of low and high molecular weight dextrans on selected serum lipid parameters. 1].[低分子量和高分子量右旋糖酐对选定血清脂质参数的影响。1]
Z Gesamte Inn Med. 1992 Jan;47(1):6-11.
9
[Comparative determination of blood dextran level and plasma volume in rabbits following administration of dextran preparations of different molecular weights].[不同分子量葡聚糖制剂给药后家兔血液中葡聚糖水平及血浆容量的比较测定]
Acta Pharm Hung. 1972;42(2):49-57.
10
A paper strip electrophoretic examination of the action of dextran in colloidal solution on human serum.葡聚糖胶体溶液对人血清作用的纸条电泳检查
Experientia. 1960 Nov 15;16:488-9. doi: 10.1007/BF02158351.

引用本文的文献

1
UP-HILIC-MS/MS to Determine the Action Pattern of Penicillium sp. Dextranase.采用亲水相互作用液相色谱-串联质谱法测定青霉菌葡聚糖酶的作用模式。
J Am Soc Mass Spectrom. 2015 Jul;26(7):1174-85. doi: 10.1007/s13361-015-1117-y. Epub 2015 May 1.
2
The characteristic specificity of plasmocytoma lipids concerning their resistance to form DL-fractions with colloidal dextran.浆细胞瘤脂质在与胶体葡聚糖形成DL级分方面的抗性的特征特异性。
Experientia. 1965 Jun 15;21(6):338-9. doi: 10.1007/BF02144702.